NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route
NY-ESO-1特异性T细胞受体工程化T细胞与TRPV2拮抗剂曲尼司特联合治疗可增强食管癌细胞的杀伤作用:一种双靶点癌症治疗途径
期刊:Cancer Cell International
影响因子:5.3
doi:10.1186/s12935-024-03249-w
Obed Boadi Amissah,Wenfang Chen,Jean de Dieu Habimana,Yirong Sun,Lihui Lin,Yujie Liu,Ling Wang,Zhaoming Liu,Omar Mukama,Rajesh Basnet,Hohua Liu,Junyi Li,Xuanyan Ding,Lingshuang Lv,Min Chen,Yalin Liang,Rongqi Huang,Zhiyuan Li
食管癌
细胞生物学
肿瘤
T细胞
T Cell Receptor
T细胞